SlideShare une entreprise Scribd logo
1  sur  27
Jornadas de economia de la
salud
June 2010
Valencia




Measuring health
services (in the
national accounts)
Paul Schreyer, OECD
Background
• Much effort spent on measuring the value of
  GDP at current prices

• Even more important: volumes.

• Difficult when
  – Products are complex with changing quality
  – There are no economically significant prices
Background
• Health services are a prime example:
  – Rapid technological change
  – Provision often by non-market suppliers


• So how are health services measured in the
  NA?

• And should this be done differently?
Background
• Recent work:
  – Eurostat (2001) & EU Regulation
  – Atkinson report (2005) and work by
    UKCMGA
  – United States: Triplett and Bosworth 2004,
    Abraham and Mackie 2006
  – OECD:
    • Handbook 2010
    • Data development: health PPPs
  – Stiglitz-Sen-Fitoussi Commission (September
    2009)
This presentation
• A few concepts
• Capturing health services and quality
  change
• Conclusions
Terminology
• Inputs
• Outputs
  – Processes without explicit quality adjustment
  – Processes with explicit quality adjustment
• Outcomes
  – Direct outcomes
  – Indirect outcomes
• Best explained by way of a graph
Inputs                        Outputs                               Outcomes

                   Process without       Process with
                                                               Direct                Indirect
                    explicit quality    explicit quality
                                                              outcome               outcome
                     adjustment           adjustment



                       Example             Example
                      education:      education: quality-    Knowledge
                      number of        adjusted number      and skills as
                   pupils/pupil hours   of pupils/pupil     measured by            Future real
                      by level of      hours by level of       scores               earnings,
                      education           education                                growth rate
Labour, capital,
                                                                                     of GDP,
 intermediate                                                                          well-
     inputs                          Example health:                                rounded
                   Example health:
                                     quality-adjusted                                citizens
                      number of
                                       number of            Health status              etc.
                       complete                             of population
                                        complete
                    treatments by
                                   treatments by type
                   type of disease
                                       of disease




                                                            Inhereted skills, socio-economic
Environmental
   factors
                                                                    background, etc.

                                                            Hygene, lifestyle, infrastructure
                                                                          etc.
Terminology
→National accounts should strive at
 measuring outputs
  →in the form of quality-adjusted processes
  →or as the marginal contribution to outcomes
→Outcomes (as used here) is indicative of
 results of the health system as a whole
→Although outcome ≠ output, they are not
 independent
Non-market production
• Nothing special in terms of the basic
  service provided, but mode of provision is
  different
• In particular: prices not economically
  significant
• Traditional way of dealing with this:
  – Value of output = value of inputs (sum of
    costs)
  – Volume of output = volume of inputs
  – Problem: defines away productivity change
From inputs to outputs
• Efforts to capture volume change of
  outputs, not of inputs
• What exactly is output of health industry?
• Target definition:
• Health service = complete treatment
  of a disease or medical service to
  prevent a disease
• But what exactly is a ‘complete treatment’?
• And how to deal with quality change?
• The long (& still incomplete) answer is
  here:
  OECD (2010); Towards Measuring the
  Volume Output of Education and Health
  Services: A Handbook

• The short answer in the slides to follow.
Completed treatment
• Pathway that an individual takes through
  heterogeneous institutions in the health
  industry in order to receive full and final
  treatment for a disease or condition.
• Not easily applicable, conceptually and
  empirically:
  – E.g., chronic diseases, data limitations
• After reality check: treatment of one
  episode of disease by a particular
  institution
•    Main point: towards disease-based
  estimates
Measuring treatments
• Required to construct disease-based
  output measures:
  – number of treatments by type of disease or
  – costs per treatment by type of disease
• Administrative sources (e.g. DRGs) have
  significantly facilitated access to such
  information (Germany, Denmark,
  Australia, France,…)
• Volume indices can then be constructed:
• Weighted average of # of treatments
• Weights: cost share of type of disease
Denmark: Input price index and output price index
          for general hospital services
             based on ~ 800 DRGs
  120.0




  115.0




  110.0




  105.0                                             Input based
                                                    Output based


  100.0




   95.0




   90.0
          2000   2001   2002   2003   2004   2005
Quality change
• Via stratification (implicit quality
  adjustment)
• Explicit quality adjustment
• Capturing quality by measuring
  marginal contribution to outcomes
Capturing quality change via
         stratification (1)
• Basic idea: matching products: services are
  stratified such that only similar services are
  compared
• Criterion for classification: similarity in effects
  on patients, and not similarity in how services
  are produced
• Example: different treatments for the same
  disease (in a particular type of establishment)
  should be in one stratum, and not similar
  medical procedures for different diseases
• Implies: most detailed stratification = not
  necessarily best choice with cost weights and
  imperfect markets
Capturing quality change via
            stratification (2)
   • 2 treatments, traditional and laser surgery
          Same effect on outcome
          Laser is cheaper
          Laser surgery diffuses progressively
                                  Traditional surgery         Laser surgery
                          Period 0 Period 1 Period 2 Period 0 Period 1 Period 2
Unit cost                        100         100      100 -            90      90
Number of interventions           50           40       5    0         10      45

Total cost                    5000     4000       500        0      900     4050


   Laspeyres volume index period 1 to period 2:
   [sT(5/40)+sL(45/10)]-1=-7.1%
   where sT=82% and sL=18% are the period 1 cost shares
Capturing quality change via
         stratification (3)
• Measured output declines! →Counter-intuitive
• Problem: 2 medical procedures have been
  treated as 2 different services
• Note also implicit assumption:
   – consumer valuation of the two ‘products’ is
     captured by the relative unit costs,
   – so if laser surgery is cheaper than traditional
     surgery, this method implicitly quality-adjusts
     downward the quantity of laser surgery when
     it is combined with traditional surgery.
Capturing quality change via
        stratification (4)
• In a perfect market, the price of the
  traditional treatment would
  instantaneously adjust downward and/or
  traditional treatment would disappear
• In practice and in a non-market context,
  this does not happen
→2 treatments should be treated as the
  same product
→no cost weighting, volume change = zero
Capturing quality change via
        stratification (5)
• A more sophisticated method would be to keep
  both treatments in the same stratum but
  explicitly adjust one of the treatments
• For example put a coefficient of 0.8 on the
  traditional treatment
• Such adjustments would have to rely on medical
  effectiveness studies
• There is some way to go before practical
  implementation

• For more on this, see Triplett (2001): What’s
  different about health? Human repair and car
  repair in national accounts and in national
  health accounts
Capturing quality change via
         stratification (6)
• Note: even if we do not explicitly quality-adjust products,
  the decision how to group them cannot be made without
  some reference to effects on outcome
• Otherwise, no statement can be made about
  substitutability of services and how they should be
  classified
• Nearly everything that has been said about quality
  adjustment via stratification applies also to market
  production
• Only difference: price statisticians or national
  accountants who have to deal with it
Capturing quality change via
      explicit adjustment
• If stratification is too granular, explicit
  quality adjustment may be needed
• Basic problems:
  – Quality is multidimensional: how to aggregate
    across dimensions? (waiting times, risk of
    suboptimal treatment...)
  – How to aggregate change in quality variable(s)
    with change in quantity (process) variables?
Capturing quality change via
measuring marginal contribution to
           outcome
• Example: QUALYs, DALYs
• Problems:
   – Making sure factors other than health care are
     controlled for;
   – Timing – lag between service and outcome
   – Putting monetary value on human lives
• Very useful avenue of research but unlikely to be
  implemented in official statistics soon
Conclusions (1)
• Output and outcome are different and should
  not be confused
• National accounts and productivity studies of
  establishments need measures of output, not of
  outcome
• But output and outcome are not independent
• In the presence of quality change, all existing
  methods require some implicit or explicit
  information or reasoning about outcome.
• Output or medical services should be based on
  treatment of disease unit of production
Conclusions (2)
• Problems of quality adjustment arise
  whether services are provided by market
  or non-market producers.
• A pragmatic approach will be called for to
  proceed with services measurement
  – no reason to approach every type of service
    with the same method for quality adjustment
  – methodologies should be robust and
    transparent
Conclusions (3)
• Measuring output for complex services is
  difficult
• But conclusion should not be that it is simply too
  difficult to do anything.
• Visible progress in the area of health due to
  availability of administrative data
• It may take a while before consensual and
  internationally comparable methods are agreed
  upon but active research and data development
  is vital to achieve this objective.
Thank you for your attention!

Contenu connexe

Similaire à Paul schreyer

An introduction to using cost-effectiveness analysis to inform spending decis...
An introduction to using cost-effectiveness analysis to inform spending decis...An introduction to using cost-effectiveness analysis to inform spending decis...
An introduction to using cost-effectiveness analysis to inform spending decis...Carmen Figueroa
 
Improving hospital profitability through cost of quality
Improving hospital profitability through cost of qualityImproving hospital profitability through cost of quality
Improving hospital profitability through cost of qualityAlexander Decker
 
Public sector productivity - Peter van de Ven, OECD
Public sector productivity - Peter van de Ven, OECDPublic sector productivity - Peter van de Ven, OECD
Public sector productivity - Peter van de Ven, OECDOECD Governance
 
PHARMACOECONOMIC_STUDIES..ppt
PHARMACOECONOMIC_STUDIES..pptPHARMACOECONOMIC_STUDIES..ppt
PHARMACOECONOMIC_STUDIES..pptashfaq22
 
2 gf h econ cost effectivness and roi
2 gf h econ cost effectivness and roi2 gf h econ cost effectivness and roi
2 gf h econ cost effectivness and roiGreg Fell
 
Comparative Effectiveness: UCSF East Africa Global Health -Kisumu 2014
Comparative Effectiveness: UCSF East Africa Global Health -Kisumu 2014Comparative Effectiveness: UCSF East Africa Global Health -Kisumu 2014
Comparative Effectiveness: UCSF East Africa Global Health -Kisumu 2014GlobalResearchUCSF
 
Quality assurance in health care
Quality assurance in health care Quality assurance in health care
Quality assurance in health care Ankita Kunwar
 
Measuring the Economic Value of Chemicals on Ecological System and Human Heal...
Measuring the Economic Value of Chemicals on Ecological System and Human Heal...Measuring the Economic Value of Chemicals on Ecological System and Human Heal...
Measuring the Economic Value of Chemicals on Ecological System and Human Heal...OECD Environment
 
Health quality and management
Health quality and managementHealth quality and management
Health quality and managementDalia El-Shafei
 
Capstone EBP fall prevention programming
Capstone EBP fall prevention programming Capstone EBP fall prevention programming
Capstone EBP fall prevention programming AmandaDiveleyMHAPTA
 
Economic evaluation: overview
Economic evaluation: overviewEconomic evaluation: overview
Economic evaluation: overviewPatricia Curmi
 
VBP, Delivery System Reform, and Health and Social Services
VBP, Delivery System Reform, and Health and Social ServicesVBP, Delivery System Reform, and Health and Social Services
VBP, Delivery System Reform, and Health and Social ServicesAndré Thompson, MPA
 
Evaluating impact of humanitarian action: a science or an art (Jo Puri, 3iE)
Evaluating impact of humanitarian action: a science or an art (Jo Puri, 3iE)Evaluating impact of humanitarian action: a science or an art (Jo Puri, 3iE)
Evaluating impact of humanitarian action: a science or an art (Jo Puri, 3iE)ALNAP
 
Health Economics in Radiation Oncology
Health Economics in Radiation OncologyHealth Economics in Radiation Oncology
Health Economics in Radiation OncologyYamini Baviskar
 
OneStart 2015 London Bootcamp: Eli Gajraj, NICE - Gatekeeper to the NHS
OneStart 2015 London Bootcamp: Eli Gajraj, NICE - Gatekeeper to the NHSOneStart 2015 London Bootcamp: Eli Gajraj, NICE - Gatekeeper to the NHS
OneStart 2015 London Bootcamp: Eli Gajraj, NICE - Gatekeeper to the NHSOxbridge Biotech Roundtable
 

Similaire à Paul schreyer (20)

An introduction to using cost-effectiveness analysis to inform spending decis...
An introduction to using cost-effectiveness analysis to inform spending decis...An introduction to using cost-effectiveness analysis to inform spending decis...
An introduction to using cost-effectiveness analysis to inform spending decis...
 
Cost concept and economic evaluation
Cost concept and economic evaluationCost concept and economic evaluation
Cost concept and economic evaluation
 
Health economics what is it
Health economics what is itHealth economics what is it
Health economics what is it
 
Improving hospital profitability through cost of quality
Improving hospital profitability through cost of qualityImproving hospital profitability through cost of quality
Improving hospital profitability through cost of quality
 
Public sector productivity - Peter van de Ven, OECD
Public sector productivity - Peter van de Ven, OECDPublic sector productivity - Peter van de Ven, OECD
Public sector productivity - Peter van de Ven, OECD
 
PHARMACOECONOMIC_STUDIES..ppt
PHARMACOECONOMIC_STUDIES..pptPHARMACOECONOMIC_STUDIES..ppt
PHARMACOECONOMIC_STUDIES..ppt
 
DRPH1.ppt
DRPH1.pptDRPH1.ppt
DRPH1.ppt
 
2 gf h econ cost effectivness and roi
2 gf h econ cost effectivness and roi2 gf h econ cost effectivness and roi
2 gf h econ cost effectivness and roi
 
Comparative Effectiveness: UCSF East Africa Global Health -Kisumu 2014
Comparative Effectiveness: UCSF East Africa Global Health -Kisumu 2014Comparative Effectiveness: UCSF East Africa Global Health -Kisumu 2014
Comparative Effectiveness: UCSF East Africa Global Health -Kisumu 2014
 
Quality assurance in health care
Quality assurance in health care Quality assurance in health care
Quality assurance in health care
 
Measuring the Economic Value of Chemicals on Ecological System and Human Heal...
Measuring the Economic Value of Chemicals on Ecological System and Human Heal...Measuring the Economic Value of Chemicals on Ecological System and Human Heal...
Measuring the Economic Value of Chemicals on Ecological System and Human Heal...
 
Health quality and management
Health quality and managementHealth quality and management
Health quality and management
 
Capstone EBP fall prevention programming
Capstone EBP fall prevention programming Capstone EBP fall prevention programming
Capstone EBP fall prevention programming
 
cost evaluation.pptx
cost evaluation.pptxcost evaluation.pptx
cost evaluation.pptx
 
Economic evaluation: overview
Economic evaluation: overviewEconomic evaluation: overview
Economic evaluation: overview
 
VBP, Delivery System Reform, and Health and Social Services
VBP, Delivery System Reform, and Health and Social ServicesVBP, Delivery System Reform, and Health and Social Services
VBP, Delivery System Reform, and Health and Social Services
 
Health economics
Health economicsHealth economics
Health economics
 
Evaluating impact of humanitarian action: a science or an art (Jo Puri, 3iE)
Evaluating impact of humanitarian action: a science or an art (Jo Puri, 3iE)Evaluating impact of humanitarian action: a science or an art (Jo Puri, 3iE)
Evaluating impact of humanitarian action: a science or an art (Jo Puri, 3iE)
 
Health Economics in Radiation Oncology
Health Economics in Radiation OncologyHealth Economics in Radiation Oncology
Health Economics in Radiation Oncology
 
OneStart 2015 London Bootcamp: Eli Gajraj, NICE - Gatekeeper to the NHS
OneStart 2015 London Bootcamp: Eli Gajraj, NICE - Gatekeeper to the NHSOneStart 2015 London Bootcamp: Eli Gajraj, NICE - Gatekeeper to the NHS
OneStart 2015 London Bootcamp: Eli Gajraj, NICE - Gatekeeper to the NHS
 

Plus de Asociación de Economía de la Salud (20)

Mike pringle
Mike pringleMike pringle
Mike pringle
 
Nancy Devlin
Nancy DevlinNancy Devlin
Nancy Devlin
 
Michael Herdman
Michael HerdmanMichael Herdman
Michael Herdman
 
Eduardo Sanchez Iriso
Eduardo Sanchez IrisoEduardo Sanchez Iriso
Eduardo Sanchez Iriso
 
Nicholas Mays
Nicholas MaysNicholas Mays
Nicholas Mays
 
David Colin Thome
David Colin ThomeDavid Colin Thome
David Colin Thome
 
Antoni Montserrat
Antoni MontserratAntoni Montserrat
Antoni Montserrat
 
Olga Delgado
Olga DelgadoOlga Delgado
Olga Delgado
 
Claire Hulme
Claire HulmeClaire Hulme
Claire Hulme
 
Manuel Bravo
Manuel Bravo Manuel Bravo
Manuel Bravo
 
Jaime Pinilla
Jaime PinillaJaime Pinilla
Jaime Pinilla
 
Jaime Prats
Jaime PratsJaime Prats
Jaime Prats
 
Juan José Ganuza
Juan José GanuzaJuan José Ganuza
Juan José Ganuza
 
Enrique Gavilan
Enrique GavilanEnrique Gavilan
Enrique Gavilan
 
Paloma Fernández
Paloma FernándezPaloma Fernández
Paloma Fernández
 
Pere Ibern
Pere IbernPere Ibern
Pere Ibern
 
Jofre Bonet, Alistair McGuire
Jofre Bonet, Alistair McGuireJofre Bonet, Alistair McGuire
Jofre Bonet, Alistair McGuire
 
José Manuel Freire
José Manuel FreireJosé Manuel Freire
José Manuel Freire
 
Jorge Relaño
Jorge RelañoJorge Relaño
Jorge Relaño
 
Xavier Martinez-Giralt
Xavier Martinez-GiraltXavier Martinez-Giralt
Xavier Martinez-Giralt
 

Paul schreyer

  • 1. Jornadas de economia de la salud June 2010 Valencia Measuring health services (in the national accounts) Paul Schreyer, OECD
  • 2. Background • Much effort spent on measuring the value of GDP at current prices • Even more important: volumes. • Difficult when – Products are complex with changing quality – There are no economically significant prices
  • 3. Background • Health services are a prime example: – Rapid technological change – Provision often by non-market suppliers • So how are health services measured in the NA? • And should this be done differently?
  • 4. Background • Recent work: – Eurostat (2001) & EU Regulation – Atkinson report (2005) and work by UKCMGA – United States: Triplett and Bosworth 2004, Abraham and Mackie 2006 – OECD: • Handbook 2010 • Data development: health PPPs – Stiglitz-Sen-Fitoussi Commission (September 2009)
  • 5. This presentation • A few concepts • Capturing health services and quality change • Conclusions
  • 6. Terminology • Inputs • Outputs – Processes without explicit quality adjustment – Processes with explicit quality adjustment • Outcomes – Direct outcomes – Indirect outcomes • Best explained by way of a graph
  • 7. Inputs Outputs Outcomes Process without Process with Direct Indirect explicit quality explicit quality outcome outcome adjustment adjustment Example Example education: education: quality- Knowledge number of adjusted number and skills as pupils/pupil hours of pupils/pupil measured by Future real by level of hours by level of scores earnings, education education growth rate Labour, capital, of GDP, intermediate well- inputs Example health: rounded Example health: quality-adjusted citizens number of number of Health status etc. complete of population complete treatments by treatments by type type of disease of disease Inhereted skills, socio-economic Environmental factors background, etc. Hygene, lifestyle, infrastructure etc.
  • 8. Terminology →National accounts should strive at measuring outputs →in the form of quality-adjusted processes →or as the marginal contribution to outcomes →Outcomes (as used here) is indicative of results of the health system as a whole →Although outcome ≠ output, they are not independent
  • 9. Non-market production • Nothing special in terms of the basic service provided, but mode of provision is different • In particular: prices not economically significant • Traditional way of dealing with this: – Value of output = value of inputs (sum of costs) – Volume of output = volume of inputs – Problem: defines away productivity change
  • 10. From inputs to outputs • Efforts to capture volume change of outputs, not of inputs • What exactly is output of health industry? • Target definition: • Health service = complete treatment of a disease or medical service to prevent a disease • But what exactly is a ‘complete treatment’? • And how to deal with quality change?
  • 11. • The long (& still incomplete) answer is here: OECD (2010); Towards Measuring the Volume Output of Education and Health Services: A Handbook • The short answer in the slides to follow.
  • 12. Completed treatment • Pathway that an individual takes through heterogeneous institutions in the health industry in order to receive full and final treatment for a disease or condition. • Not easily applicable, conceptually and empirically: – E.g., chronic diseases, data limitations • After reality check: treatment of one episode of disease by a particular institution • Main point: towards disease-based estimates
  • 13. Measuring treatments • Required to construct disease-based output measures: – number of treatments by type of disease or – costs per treatment by type of disease • Administrative sources (e.g. DRGs) have significantly facilitated access to such information (Germany, Denmark, Australia, France,…) • Volume indices can then be constructed: • Weighted average of # of treatments • Weights: cost share of type of disease
  • 14. Denmark: Input price index and output price index for general hospital services based on ~ 800 DRGs 120.0 115.0 110.0 105.0 Input based Output based 100.0 95.0 90.0 2000 2001 2002 2003 2004 2005
  • 15. Quality change • Via stratification (implicit quality adjustment) • Explicit quality adjustment • Capturing quality by measuring marginal contribution to outcomes
  • 16. Capturing quality change via stratification (1) • Basic idea: matching products: services are stratified such that only similar services are compared • Criterion for classification: similarity in effects on patients, and not similarity in how services are produced • Example: different treatments for the same disease (in a particular type of establishment) should be in one stratum, and not similar medical procedures for different diseases • Implies: most detailed stratification = not necessarily best choice with cost weights and imperfect markets
  • 17. Capturing quality change via stratification (2) • 2 treatments, traditional and laser surgery Same effect on outcome Laser is cheaper Laser surgery diffuses progressively Traditional surgery Laser surgery Period 0 Period 1 Period 2 Period 0 Period 1 Period 2 Unit cost 100 100 100 - 90 90 Number of interventions 50 40 5 0 10 45 Total cost 5000 4000 500 0 900 4050 Laspeyres volume index period 1 to period 2: [sT(5/40)+sL(45/10)]-1=-7.1% where sT=82% and sL=18% are the period 1 cost shares
  • 18. Capturing quality change via stratification (3) • Measured output declines! →Counter-intuitive • Problem: 2 medical procedures have been treated as 2 different services • Note also implicit assumption: – consumer valuation of the two ‘products’ is captured by the relative unit costs, – so if laser surgery is cheaper than traditional surgery, this method implicitly quality-adjusts downward the quantity of laser surgery when it is combined with traditional surgery.
  • 19. Capturing quality change via stratification (4) • In a perfect market, the price of the traditional treatment would instantaneously adjust downward and/or traditional treatment would disappear • In practice and in a non-market context, this does not happen →2 treatments should be treated as the same product →no cost weighting, volume change = zero
  • 20. Capturing quality change via stratification (5) • A more sophisticated method would be to keep both treatments in the same stratum but explicitly adjust one of the treatments • For example put a coefficient of 0.8 on the traditional treatment • Such adjustments would have to rely on medical effectiveness studies • There is some way to go before practical implementation • For more on this, see Triplett (2001): What’s different about health? Human repair and car repair in national accounts and in national health accounts
  • 21. Capturing quality change via stratification (6) • Note: even if we do not explicitly quality-adjust products, the decision how to group them cannot be made without some reference to effects on outcome • Otherwise, no statement can be made about substitutability of services and how they should be classified • Nearly everything that has been said about quality adjustment via stratification applies also to market production • Only difference: price statisticians or national accountants who have to deal with it
  • 22. Capturing quality change via explicit adjustment • If stratification is too granular, explicit quality adjustment may be needed • Basic problems: – Quality is multidimensional: how to aggregate across dimensions? (waiting times, risk of suboptimal treatment...) – How to aggregate change in quality variable(s) with change in quantity (process) variables?
  • 23. Capturing quality change via measuring marginal contribution to outcome • Example: QUALYs, DALYs • Problems: – Making sure factors other than health care are controlled for; – Timing – lag between service and outcome – Putting monetary value on human lives • Very useful avenue of research but unlikely to be implemented in official statistics soon
  • 24. Conclusions (1) • Output and outcome are different and should not be confused • National accounts and productivity studies of establishments need measures of output, not of outcome • But output and outcome are not independent • In the presence of quality change, all existing methods require some implicit or explicit information or reasoning about outcome. • Output or medical services should be based on treatment of disease unit of production
  • 25. Conclusions (2) • Problems of quality adjustment arise whether services are provided by market or non-market producers. • A pragmatic approach will be called for to proceed with services measurement – no reason to approach every type of service with the same method for quality adjustment – methodologies should be robust and transparent
  • 26. Conclusions (3) • Measuring output for complex services is difficult • But conclusion should not be that it is simply too difficult to do anything. • Visible progress in the area of health due to availability of administrative data • It may take a while before consensual and internationally comparable methods are agreed upon but active research and data development is vital to achieve this objective.
  • 27. Thank you for your attention!